Gusacitinib

N/A

Report date: 2025/04/29 21:23:13
NME

Base Information

Drug NameGusacitinib
Drug Alias NameASN-002EN-3351
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitorsJanus kinase inhibitors
TargetsJanus kinaseSpleen tyrosine kinase
Therapy Area/IndicationsEczemaDermatitisLupus Erythematosus, Systemic +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAsana Biosciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrialspark IncSanofiNational Institute Of Arthritis And Musculoskeletal And Skin Diseases +[4] 
Active IndicationsN/A
Inactive IndicationsEczemaDermatitisLupus Erythematosus, Systemic +[14] 

Other Information

ATC CodeN/A
Related LinksN/A